https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520Credit%2520Suisse%2520w%2520non%2520GAAP%25206%252025%25202014.pdf
S&P 500
All time high of
$42.47
June 6th, 2014
PolyOne Corporation Page 9
2006 Q1 2014 2015
“Where we were” “Where we are” Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 13.8% 12 – 16%
Global Specialty Engineered
Materials
1.1% 11.6% 12 – 16%
Designed Structures & Solutions -- 6.5% 8 – 10%
Performance Products &
Solutions
5.5% 7.7% 9 – 12%
Distribution 2.6% 6.1% 6 – 7.5%
2) Specialty Platform % of
Operating Income
6.0% 64% 65 – 75%
3) ROIC* 5.0% 9.4% 15%
4) Adjusted EPS Growth N/A 42%
Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
PolyOne Corporation Page 10
Bridge to $2.50 Adjusted EPS by 2015
2015 EPS: $2.50
2013 EPS: $1.31
Continued Gross Margin
Expansion
Mergers & Acquisitions
Spartech Accretion
Incremental Share Buybacks
Ongoing LSS Programs
(50-100 bps/yr)
Accelerated Innovation
& Mix Improvement
Several Levers to
Drive Growth
Mid Single Digit Revenue CAGR
PolyOne Corporation Page 11
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
$20
$53
2006 2013
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index
Progression*
14.3%
30.7%
2006 2013
Specialty Platform
Gross Margin %
19.5%
43.0%
2006 2013
Specialty Vitality Index Target ≥ 35%
PolyOne Corporation Page 12
Healthcare
Consumer
Packaging and Additive Technology
Transportation
Unique and Innovative Solutions
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG
PolyOne Corporation Page 13
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 14
60%
100%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2014
Pension Funding**
As of March 31, 2014
Debt Maturities & Pension Funding – 3/31/14
Net Debt / EBITDA* = 1.9x
$48
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of March 31, 2014
($ millions)
Coupon Rates: 7.500% 7.375% 5.250%
** includes US-qualified pension plans only *TTM 3/31/2014
PolyOne Corporation Page 15
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
$0.16
$0.20
$0.24
$0.32
$0.10
$0.20
$0.30
$0.40
2011 2012 2013 2014
Annual Dividend
Expanding our sales, marketing,
and technical capabilities
Targets that expand our:
• Specialty offerings
• End market presence
• Geographic footprint
• Operating Margin
Synergy opportunities
Adjacent material solutions
Repurchased 1.4 million shares in
Q1 2014
Repurchased 6.4 million
shares since April 2013
13.6 million shares are
available for
repurchase under the
current authorization
Organic
Growth
Acquisitions
Share
Repurchases
Dividends
Investing in operational and
LSS initiatives (including
synergy capture)
Manufacturing alignment
PolyOne Corporation Page 16
Formula for Success
Innovation
Market
Beating
Performance
Excellence in Execution
PolyOne Corporation Page 17
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
Platform operating income mix percentage 2005Y* 2008Y* 2010Y* 2013Y 2014 Q1
Global Specialty Engineered Materials $ 0.4 $ 17.6 $ 49.7 $ 57.2 $ 18.3
Global Color, Additives and Inks 4.3 28.1 37.7 104.0 30.4
Designed Structures and Solutions - - - 33.4 11.2
Specialty Platform $ 4.7 $ 45.7 $ 87.4 $ 194.6 $ 59.9
Performance Products and Solutions 75.7 31.3 54.0 56.0 16.0
Distribution 19.5 28.1 42.0 63.3 17.2
SunBelt Joint venture 91.9 28.6 18.9 - -
Corporate (51.5) (425.1) (27.7) (82.4) (36.7)
Operating income (loss) GAAP $ 140.3 $ (291.4) $ 174.6 $ 231.5 $ 56.4
Less: Corporate operating expense 51.5 425.1 27.7 82.4 36.7
Operating income excluding Corporate $ 191.8 $ 133.7 $ 202.3 $ 313.9 $ 93.1
Specialty platform operating mix percentage 2% 34% 43% 62% 64%
* Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520GS%2520w%2520non%2520GAAP%25205_21_14.pdf
S&P 500
All time high of
$39.55
May 13th, 2014
Page 8
2006 Q1 2014 2015
“Where we were” “Where we are” Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 13.8% 12 – 16%
Global Specialty Engineered
Materials 1.1% 11.6% 12 – 16%
Designed Structures & Solutions -- 6.5% 8 – 10%
Performance Products &
Solutions 5.5% 7.7% 9 – 12%
Distribution 2.6% 6.1% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 64% 65 – 75%
3) ROIC* 5.0% 9.4% 15%
4) Adjusted EPS Growth N/A 42% Double Digit Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Page 9
Bridge to $2.50 Adjusted EPS by 2015
2015 EPS: $2.50
2013 EPS: $1.31
Continued Gross Margin
Expansion
Mergers & Acquisitions
Spartech Accretion
Incremental share buybacks
Ongoing LSS Programs
(50-100 bps/yr)
Accelerated Innovation
& Mix Improvement Several Levers to
Drive Growth
Mid single digit revenue CAGR
Page 10
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
Page 11
$20
$53
2006 2013
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
14.3%
30.7%
2006 2013
Specialty Platform
Gross Margin %
19.5%
43.0%
2006 2013
Healthcare
Consumer
Packaging and Additive Technology
Transportation
Page 12
Unique and Innovative Solutions
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG
60%
100%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2014
Pension Funding**
As of March 31, 2014
Debt Maturities & Pension Funding – 3/31/14
Net Debt / EBITDA* = 1.9x
$48
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of March 31, 2014
($ millions)
Coupon Rates: 7.500% 7.375% 5.250%
** includes US-qualified pension plans only *TTM 3/31/2014
Page 13
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
$0.16
$0.20
$0.24
$0.32
$0.10
$0.20
$0.30
$0.40
2011 2012 2013 2014
Annual Dividend
Expanding our sales, marketing, and
technical capabilities
Targets that expand our:
• Specialty offerings
• End market presence
• Geographic footprint
• Operating Margin
Synergy opportunities
Adjacent material solutions
Repurchased 1.4 million shares in Q1
2014
Repurchased 6.4 million shares
since April 2013
13.6 million shares are
available for repurchase
under the current
authorization
Organic
Growth
Acquisitions
Share
Repurchases
Dividends
Investing in operational and
LSS initiatives (including
synergy capture)
Manufacturing alignment
Page 14
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
Platform operating income mix percentage 2005Y* 2008Y* 2010Y* 2013Y 2014 Q1
Global Specialty Engineered Materials $ 0.4 $ 17.6 $ 49.7 $ 57.2 $ 18.3
Global Color, Additives and Inks 4.3 28.1 37.7 104.0 30.4
Designed Structures and Solutions - - - 33.4 11.2
Specialty Platform $ 4.7 $ 45.7 $ 87.4 $ 194.6 $ 59.9
Performance Products and Solutions 75.7 31.3 54.0 56.0 16.0
Distribution 19.5 28.1 42.0 63.3 17.2
SunBelt Joint venture 91.9 28.6 18.9 - -
Corporate (51.5) (425.1) (27.7) (82.4) (36.7)
Operating income (loss) GAAP $ 140.3 $ (291.4) $ 174.6 $ 231.5 $ 56.4
Less: Corporate operating expense 51.5 425.1 27.7 82.4 36.7
Operating income excluding Corporate $ 191.8 $ 133.7 $ 202.3 $ 313.9 $ 93.1
Specialty platform operating mix percentage 2% 34% 43% 62% 64%
* Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.
https://www.avient.com/sites/default/files/2024-12/Terms and Conditions of Sale for France.pdf
Buyer assumes all risks and liabilities (i) arising out of unloading, discharge, storage, handling and use of the Product, or
(ii) arising out of compliance or non-compliance with laws and regulations governing or controlling such activity.
Re-Sale and Re-Export; Compliance with Laws.
Compliance with Laws.
https://www.avient.com/sites/default/files/2023-03/2023 Paddlesports Application Bulletin.pdf
APPLICATION BULLETIN
STRENGTH & FLEX
Excellent Dimensional Stability,
High Stiffness, Impact Resistance
SOLUTION: Short & Long Fiber
Formulations, Continuous Fiber
Composite Tapes & Laminates
DURABILITY
Density, Stiffness, Strength
SOLUTION: Short & Long Fiber
Formulations
SURFACE PROTECTION
Performance Enhancements, Chemical Resistance
SOLUTION: Scratch & Mar Resistance,
UV Stable Additives
TACTILE EXPERIENCE
Soft Touch, Slip Resistance
SOLUTION: Thermoplastic
Elastomers
METAL REPLACEMENT
High Stiffness-to-Weight Ratio,
Lightweighting, Buoyancy
SOLUTION: Continuous Filament
Winding Technology
EXTREME
PERFORMANCE
Waterproof Seals
& Closures
SOLUTION: Thermoplastic
Elastomers
DYNAMIC COMFORT
Durability, Customization,
Shock Absorption
SOLUTION: Thermoplastic
Elastomers
COLOR RESILIENCE
Excellent Adhesion
to Substrates,
Weatherability
SOLUTION: Plastisol
Textile Inks
FUNCTIONALITY
High Stiffness, Structural Integrity,
Metal Replacement
SOLUTION: Short & Long Fiber
Formulations, Continuous Fiber Composite
Tapes & Laminates
AESTHETIC APPEAL
Custom Colors, Patterns
& Tones
SOLUTION: Custom Polymer
Colorants, Specialty Additives
RESILIENCE
Weatherability, Longevity
SOLUTION: Specialty
Engineered Polymer
Formulations
STEM TO STERN
OUTSTANDING FROM
Explore the many ways polymers can help you innovate to
meet evolving consumer demands and create thoughtfully
designed paddlesports products that set your brand apart.
https://www.avient.com/sites/default/files/2023-08/EVSE Industry Bulletin.pdf
Materials need to meet regulations (such as
UL flammability compliance), be hygienic, and
provide flexibility in design for options such as
lightweighting or varied exterior finishes.
This literature shall NOT operate as permission, recommendation, or inducement to practice any patented invention without permission of the patent owner.
1.844.4AVIENT
www.avient.com
ADDITIVE TECHNOLOGIES
Flame retardant additives Mitigates fire hazard by reducing flame spread and heat release
Anti-static and conductive additives Controls build-up of static charges to reduce risk of fire and enhance safety
Antimicrobial technology
Reduces bacterial, mold and fungal growth on the surface and through the
thickness of the part
Light spectrum management
Provides UV protection to prevent discoloration or degradation of
mechanical properties for lasting outdoor durability and color fastness
Scratch and mar resistant additives Adds protection to stand up to surface abrasion and wear and tear
COLORANT TECHNOLOGIES
UL 94 colorants
Over 2,000 UL 94-recognized color concentrates, including for
high temperature resins
Special effect colorants Visual enhancements including metallic, granite, or pearlescent appearance
Bio colorants and additives For use in bio-based plastics without compromising performance
TECHNOLOGIES AVAILABLE TO ENHANCE PUBLIC CHARGING STATIONS
Avient supports all of these solutions with a range of world-class services, including:
• Polymer material expertise with a focus on sustainability
• Application development expertise with global design centers
• Regulatory compliance coordination to help mitigate risk
• Reliable field technical services and support
• Leading color trend and design services
https://www.avient.com/sites/default/files/2023-03/Mevopur Healthcare Functional Additives Nucleating Application Bulletin.pdf
REGULATORY SUPPORT
• Drug delivery devices
• Pharmaceutical packaging
• Medical equipment
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified sites,
providing global consistency and increased
security of supply
• Documented change control beyond CAS
number level, reducing the risk of change
• Allows crystallization in semi-crystalline
polymers to begin faster and complete earlier
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1 and USP biological
evaluation
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
• Registered Drug Master File (Type III) and/or
Device Master File
• Food contact established with FDA/EU*
APPLICATION BULLETIN
* FDA/EU compliance information available upon request
Healthcare use limitations apply—see below.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including
the suitability of all raw materials and components used for its manufacture.
https://www.avient.com/sites/default/files/2022-12/Renol Fiber Colorants Black Colorants for PET and PA Fibers Product Bulletin.pdf
KEY CHARACTERISTICS
• Excellent lot-to-lot and within-lot consistency for
high-quality homogeneous black shades
• Easy processing and support of a long-lasting
spin pack lifetime
• Fastness properties and specification tolerances
on par with high-end products on the market
• Standard and bluish undertones available
in high pigment loadings for an efficient and
competitive coloration package
• Can be combined with additives into a single
combination concentrate for convenience
• Compliance with global, regional, and local
standards and regulations*
RECOMMENDED USE
• In most cases, the concentrate is added
directly to the resin using gravimetric or
volumetric dosing units; for some processes,
the concentrate can be added via a side stream
extruder (direct spinning)
• The recommended dosages are from 3% for
the typical automotive, technical, and carpet
applications and up to 6% for apparel, footwear,
and home textile yarns
* Contact your local sales representative for more information on
regulatory compliance
PRODUCT BULLETIN
Copyright © 2022, Avient Corporation.
https://www.avient.com/sites/default/files/2020-09/oncolor-sc-product-bulletin-8.5x11.pdf
You can expect that the materials we produce contain only
ingredients that conform to accepted legal and regulatory
compliance guidelines
When you choose Avient, you can be confident that our products will
help you meet or exceed today’s stringent compliance standards.
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for South Africa.pdf
Buyer
assumes all risks and liabilities (i) arising out of unloading,
discharge, storage, handling and use of the Product, or (ii) arising
out of compliance or non-compliance with national, state,
provincial, or local laws and regulations governing or controlling
such activity.
Re-Sale and Re-Export; Compliance with Laws.
Buyer shall be exclusively responsible for (i) ensuring
compliance with all Laws and Standards associated with its intended
use of Product; and (ii) obtaining all necessary approvals, permits or
clearances for such use.
https://www.avient.com/sites/default/files/2024-12/Terms and Conditions of Sale for Indonesia %28English translation%29.pdf
Buyer
assumes all risks and liabilities (i) arising out of unloading,
discharge, storage, handling and use of the Product, or (ii) arising
out of compliance or non-compliance with national, state,
provincial, or local laws and regulations governing or controlling
such activity.
Re-Sale and Re-Export; Compliance with Laws.
Buyer shall be exclusively responsible for (i) ensuring
compliance with all Laws and Standards associated with its intended
use of Product; and (ii) obtaining all necessary approvals, permits or
clearances for such use.